22
Views
82
CrossRef citations to date
0
Altmetric
Cell Growth and Development

BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site

, , , &
Pages 4843-4854 | Received 06 Jan 1999, Accepted 26 Mar 1999, Published online: 28 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Donato F. Romagnolo, Ryan B. Chirnomas, Jennifer Ku, Brandon D. Jeffy, Claire M. Payne, Hana Holubec, Lois Ramsey, Harris Bernstein, Carol Bernstein, Kathleen Kunke, Achyut Bhattacharyya, James Warneke & Harinder Garewal. (2003) Deoxycholate, an Endogenous Tumor Promoter and DNA Damaging Agent, Modulates BRCA-1 Expression in Apoptosis-Sensitive Epithelial Cells: Loss of BRCA-1 Expression in Colonic Adenocarcinomas. Nutrition and Cancer 46:1, pages 82-92.
Read now
Tiho Miralem & Hava Karsenty Avraham. (2003) Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus. Molecular and Cellular Biology 23:2, pages 579-593.
Read now
Bing Hu, Jayashree Mitra, Sander van den Heuvel & Greg H. Enders. (2001) S and G2 Phase Roles for Cdk2 Revealed by Inducible Expression of a Dominant-Negative Mutant in Human Cells. Molecular and Cellular Biology 21:8, pages 2755-2766.
Read now
Paz Arizti, Li Fang, Iha Park, Yuxin Yin, Ellen Solomon, Toru Ouchi, Stuart A. Aaronson & Sam W. Lee. (2000) Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression. Molecular and Cellular Biology 20:20, pages 7450-7459.
Read now

Articles from other publishers (78)

Amirreza Mansoori-Kermani, Sadaf Khalighi, Iman Akbarzadeh, Fazeleh Ranjbar Niavol, Hamidreza Motasadizadeh, Athar Mahdieh, Vahid Jahed, Masoud Abdinezhad, Nikoo Rahbariasr, Mahshid Hosseini, Nima Ahmadkhani, Behnam Panahi, Yousef Fatahi, Masoud Mozafari, Alan Prem Kumar & Ebrahim Mostafavi. (2022) Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. Materials Today Bio 16, pages 100349.
Crossref
Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, Pushkar Dakle, Cao Zeya, Deepika Kanojia, Wee-Joo Chng, S. Tiong Ong & H. Phillip Koeffler. (2022) THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. International Journal of Molecular Sciences 23:3, pages 1207.
Crossref
Diar Aziz, Neil Portman, Kristine J. Fernandez, Christine Lee, Sarah Alexandrou, Alba Llop-Guevara, Zoe Phan, Aliza Yong, Ashleigh Wilkinson, C. Marcelo Sergio, Danielle Ferraro, Dariush Etemadmoghadam, David D. Bowtell, Violeta Serra, Paul Waring, Elgene Lim & C. Elizabeth Caldon. (2021) Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition. npj Breast Cancer 7:1.
Crossref
Rustem E. Uzbekov & Tomer Avidor-Reiss. (2020) Principal Postulates of Centrosomal Biology. Version 2020. Cells 9:10, pages 2156.
Crossref
Iman Akbarzadeh, Mohammad Tavakkoli Yaraki, Saeedeh Ahmadi, Mohsen Chiani & Dariush Nourouzian. (2020) Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: An in-vitro investigation. Advanced Powder Technology 31:9, pages 4064-4071.
Crossref
Mingxing Teng, Jie Jiang, Zhixiang He, Nicholas P. Kwiatkowski, Katherine A. Donovan, Caitlin E. Mills, Chiara Victor, John M. Hatcher, Eric S. Fischer, Peter K. Sorger, Tinghu Zhang & Nathanael S. Gray. (2020) Development of CDK2 and CDK5 Dual Degrader TMX‐2172. Angewandte Chemie International Edition 59:33, pages 13865-13870.
Crossref
Mingxing Teng, Jie Jiang, Zhixiang He, Nicholas P. Kwiatkowski, Katherine A. Donovan, Caitlin E. Mills, Chiara Victor, John M. Hatcher, Eric S. Fischer, Peter K. Sorger, Tinghu Zhang & Nathanael S. Gray. (2020) Development of CDK2 and CDK5 Dual Degrader TMX‐2172. Angewandte Chemie 132:33, pages 13969-13974.
Crossref
Yoko Katsuki, Penny A. Jeggo, Yuki Uchihara, Minoru Takata & Atsushi Shibata. (2020) DNA double-strand break end resection: a critical relay point for determining the pathway of repair and signaling. Genome Instability & Disease 1:4, pages 155-171.
Crossref
Madalena Tarsounas & Patrick Sung. (2020) The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication. Nature Reviews Molecular Cell Biology 21:5, pages 284-299.
Crossref
Claire Gourzones, Caroline Bret & Jerome Moreaux. (2019) Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma. Frontiers in Genetics 10.
Crossref
Sachin VermaNarayana YeddulaYasushi SodaQuan ZhuGerald PaoJames Moresco, Jolene K. DiedrichAudrey Hong, Steve Plouffe, Toshiro Moroishi, Kun-Liang Guan & Inder M. Verma. (2019) BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling. Proceedings of the National Academy of Sciences 116:15, pages 7363-7370.
Crossref
Jinyu Li, Jörg Vervoorts, Paolo Carloni, Giulia Rossetti & Bernhard Lüscher. (2017) Structural prediction of the interaction of the tumor suppressor p27KIP1 with cyclin A/CDK2 identifies a novel catalytically relevant determinant. BMC Bioinformatics 18:1.
Crossref
S. Liang, S. R. Esswein, T. Ochi, Q. Wu, D. B. Ascher, D. Chirgadze, B. L. Sibanda & T. L. Blundell. (2016) Achieving selectivity in space and time with DNA double-strand-break response and repair: molecular stages and scaffolds come with strings attached. Structural Chemistry 28:1, pages 161-171.
Crossref
Leonardo K. Teixeira & Steven I. Reed. 2017. DNA Replication. DNA Replication 527 547 .
Patrick E. Gygli, Joshua C. Chang, Hamza N. Gokozan, Fay P. Catacutan, Theresa A. Schmidt, Behiye Kaya, Mustafa Goksel, Faisal S. Baig, Shannon Chen, Amelie Griveau, Wojciech Michowski, Michael Wong, Kamalakannan Palanichamy, Piotr Sicinski, Randy J. Nelson, Catherine Czeisler & José J. Otero. (2016) Cyclin A2 promotes DNA repair in the brain during both development and aging. Aging 8:7, pages 1540-1570.
Crossref
David A. Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby & Robert J. Shmookler Reis. (2016) A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition. Molecular Cancer Therapeutics 15:2, pages 241-250.
Crossref
K. Luo, M. Deng, Y. Li, C. Wu, Z. Xu, J. Yuan & Z. Lou. (2015) CDK-mediated RNF4 phosphorylation regulates homologous recombination in S-phase. Nucleic Acids Research 43:11, pages 5465-5475.
Crossref
Liam Cornell, Neil Johnson & Geoffrey I. Shapiro. 2015. PARP Inhibitors for Cancer Therapy. PARP Inhibitors for Cancer Therapy 413 430 .
R Drost & J Jonkers. (2013) Opportunities and hurdles in the treatment of BRCA1-related breast cancer. Oncogene 33:29, pages 3753-3763.
Crossref
Lu Wang, Wenjing Liu, Weidong Zhao, Gendi Song, Guishuan Wang, Xiaorong Wang & Fei Sun. (2014) Phosphorylation of CDK2 on Threonine 160 Influences Silencing of Sex Chromosome During Male Meiosis1. Biology of Reproduction 90:6.
Crossref
Eric Tram, Sevtap Savas & Hilmi Ozcelik. (2013) Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2. PLoS ONE 8:5, pages e62468.
Crossref
Carla Manuela Abreu, Ramesh Kumar, Danielle Hamilton, Andrew William Dawdy, Kevin Creavin, Sarah Eivers, Karen Finn, Jeremy Lynn Balsbaugh, Rosemary O'Connor, Patrick A. Kiely, Jeffrey Shabanowitz, Donald F. Hunt, Muriel Grenon & Noel Francis Lowndes. (2013) Site-Specific Phosphorylation of the DNA Damage Response Mediator Rad9 by Cyclin-Dependent Kinases Regulates Activation of Checkpoint Kinase 1. PLoS Genetics 9:4, pages e1003310.
Crossref
Karen Finn, Noel Francis Lowndes & Muriel Grenon. (2011) Eukaryotic DNA damage checkpoint activation in response to double-strand breaks. Cellular and Molecular Life Sciences 69:9, pages 1447-1473.
Crossref
Hyo Jin Kang, Young Bin Hong, Hee Jeong Kim, Antai Wang & Insoo Bae. (2012) Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells. Toxicology Letters 209:2, pages 154-160.
Crossref
Suhwan Chang, Rui-Hong Wang, Keiko Akagi, Kyung-Ae Kim, Betty K Martin, Luca Cavallone, Diana C Haines, Mark Basik, Phuong Mai, Elizabeth Poggi, Claudine Isaacs, Lai M Looi, Kein S Mun, Mark H Greene, Stephen W Byers, Soo H Teo, Chu-Xia Deng & Shyam K Sharan. (2011) Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nature Medicine 17:10, pages 1275-1282.
Crossref
Tomohiko Ohta, Ko Sato & Wenwen Wu. (2011) The BRCA1 ubiquitin ligase and homologous recombination repair. FEBS Letters 585:18, pages 2836-2844.
Crossref
Said Akli, Carolyn S. Van Pelt, Tuyen Bui, Laurent Meijer & Khandan Keyomarsi. (2011) Cdk2 is Required for Breast Cancer Mediated by the Low-Molecular-Weight Isoform of Cyclin E. Cancer Research 71:9, pages 3377-3386.
Crossref
Ian Hammond-Martel, Helen Pak, Helen Yu, Raphael Rouget, Andrew A. Horwitz, Jeffrey D. Parvin, Elliot A. Drobetsky & El Bachir Affar. (2010) PI 3 Kinase Related Kinases-Independent Proteolysis of BRCA1 Regulates Rad51 Recruitment during Genotoxic Stress in Human Cells. PLoS ONE 5:11, pages e14027.
Crossref
Antonio Cerqueira, David Santamaría, Bárbara Martínez-Pastor, Miriam Cuadrado, Oscar Fernández-Capetillo & Mariano Barbacid. (2009) Overall Cdk activity modulates the DNA damage response in mammalian cells. Journal of Cell Biology 187:6, pages 773-780.
Crossref
Suhwan Chang, Kajal Biswas, Betty K. Martin, Stacey Stauffer & Shyam K. Sharan. (2009) Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. Journal of Clinical Investigation 119:10, pages 3160-3171.
Crossref
Neil Johnson, Dongpo Cai, Richard D. Kennedy, Shailja Pathania, Mansi Arora, Yu-Chen Li, Alan D. D'Andrea, Jeffrey D. Parvin & Geoffrey I. Shapiro. (2009) Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage. Molecular Cell 35:3, pages 327-339.
Crossref
Alberto Viera, Julio S. Rufas, Inés Martínez, José L. Barbero, Sagrario Ortega & José A. Suja. (2009) CDK2 is required for proper homologous pairing, recombination and sex-body formation during male mouse meiosis. Journal of Cell Science 122:12, pages 2149-2159.
Crossref
Malinee PongsaveeVichanan YamkamonSumana DakengPornchai O-CharoenratDuncan R. SmithGrady F. SaundersPimpicha Patmasiriwat. (2009) The BRCA1 3′-UTR: 5711+421T/T_5711+1286T/T Genotype Is a Possible Breast and Ovarian Cancer Risk Factor . Genetic Testing and Molecular Biomarkers 13:3, pages 307-317.
Crossref
Marc S. Cortese, Vladimir N. Uversky & A. Keith Dunker. (2008) Intrinsic disorder in scaffold proteins: Getting more from less. Progress in Biophysics and Molecular Biology 98:1, pages 85-106.
Crossref
Chia-Ying Yang, Chao-Hui Chang, Ya-Ling Yu, Tsu-Chun Emma Lin, Sheng-An Lee, Chueh-Chuan Yen, Jinn-Moon Yang, Jin-Mei Lai, Yi-Ren Hong, Tzu-Ling Tseng, Kun-Mao Chao & Chi-Ying F. Huang. (2008) PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database. Bioinformatics 24:16, pages i14-i20.
Crossref
Dana Branzei & Marco Foiani. (2008) Regulation of DNA repair throughout the cell cycle. Nature Reviews Molecular Cell Biology 9:4, pages 297-308.
Crossref
Zuzana Bencokova, Laurianne Pauron, Clément Devic, Aurélie Joubert, Jérôme Gastaldo, Catherine Massart, Jacques Balosso & Nicolas Foray. (2007) Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin. Journal of Neuro-Oncology 86:1, pages 13-21.
Crossref
K Kehn, R Berro, A Alhaj, M E Bottazzi, W-I Yeh, Z Klase, R Van Duyne, S Fu & F Kashanchi. (2007) Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. Oncogene 26:35, pages 5060-5069.
Crossref
Andrew J. Deans, Kum Kum Khanna, Carolyn J. McNees, Ciro Mercurio, Jörg Heierhorst & Grant A. McArthur. (2006) Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and Is a Therapeutic Target in BRCA1-Deficient Cancers. Cancer Research 66:16, pages 8219-8226.
Crossref
A. Keith Dunker, Marc S. Cortese, Pedro Romero, Lilia M. Iakoucheva & Vladimir N. Uversky. (2005) Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS Journal 272:20, pages 5129-5148.
Crossref
Marianne Santaguida & Alain Nepveu. (2005) Differential Regulation of CDP/Cux p110 by Cyclin A/Cdk2 and Cyclin A/Cdk1. Journal of Biological Chemistry 280:38, pages 32712-32721.
Crossref
Atish D. Choudhury, Hong Xu, Ami P. Modi, Wenzhu Zhang, Thomas Ludwig & Richard Baer. (2005) Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells. Journal of Biological Chemistry 280:26, pages 24669-24679.
Crossref
Chun Shik Park, Sung Il Kim, Mi Su Lee, Cho-ya Youn, Dae Joong Kim, Eek-hoon Jho & Woo Keun Song. (2004) Modulation of β-Catenin Phosphorylation/Degradation by Cyclin-dependent Kinase 2. Journal of Biological Chemistry 279:19, pages 19592-19599.
Crossref
Kimberly A Brown, Richard L Roberts, Carlos L Arteaga & Brian K Law. (2004) Transforming growth factor-β induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein. Breast Cancer Research 6:2.
Crossref
Eliot M Rosen, Saijun Fan, Richard G Pestell & Itzhak D Goldberg. (2003) BRCA1 in hormone-responsive cancers. Trends in Endocrinology & Metabolism 14:8, pages 378-385.
Crossref
Susan A Krum, James E Womack & Timothy F Lane. (2003) Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity. Oncogene 22:38, pages 6032-6044.
Crossref
Thomas R Berton, Takashi Matsumoto, Angustias Page, Claudio J Conti, Chu-Xia Deng, José L Jorcano & David G Johnson. (2003) Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 22:35, pages 5415-5426.
Crossref
N K Dhillon & M Mudryj. (2003) Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes & Immunity 4:5, pages 336-342.
Crossref
Eliot M. Rosen, Saijun Fan, Richard G. Pestell & Itzhak D. Goldberg. (2003) BRCA1 gene in breast cancer. Journal of Cellular Physiology 196:1, pages 19-41.
Crossref
Richard C. Gregory, Toshiyasu Taniguchi & Alan D. D’Andrea. (2003) Regulation of the Fanconi anemia pathway by monoubiquitination. Seminars in Cancer Biology 13:1, pages 77-82.
Crossref
Shinya Okada & Toru Ouchi. (2003) Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization. Journal of Biological Chemistry 278:3, pages 2015-2020.
Crossref
Antony M Carr. (2002) DNA structure dependent checkpoints as regulators of DNA repair. DNA Repair 1:12, pages 983-994.
Crossref
Toshiyasu TaniguchiIrene Garcia-HigueraPaul R. AndreassenRichard C. GregoryMarkus GrompeAlan D. D'Andrea. (2002) S-phase–specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:7, pages 2414-2420.
Crossref
Dianne C. Daniel. (2002) Highlight: BRCA1 and BRCA2 proteins in breast cancer. Microscopy Research and Technique 59:1, pages 68-83.
Crossref
Chu-Xia Deng. (2002) Roles of BRCA1 in centrosome duplication. Oncogene 21:40, pages 6222-6227.
Crossref
Betsy Bove, Roland Dunbrack & Andrew Godwin. 2002. Breast Cancer. Breast Cancer 555 624 .
Navdeep K Dhillon & Maria Mudryj. (2002) Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene 21:30, pages 4626-4634.
Crossref
Thomas Caspari, Johanne M. Murray & Antony M. Carr. (2002) Cdc2–cyclin B kinase activity links Crb2 and Rqh1–topoisomerase III. Genes & Development 16:10, pages 1195-1208.
Crossref
Ralph Scully & Nadine Puget. (2002) BRCA1 and BRCA2 in hereditary breast cancer. Biochimie 84:1, pages 95-102.
Crossref
Ingrid A. Hedenfalk, Markus Ringnér, Jeffrey M. Trent & Ake Borg. 2002. 1 34 .
Steven G Brodie, Xiaoling Xu, Wenhui Qiao, Wen-Mei Li, Liu Cao & Chu-Xia Deng. (2001) Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20:51, pages 7514-7523.
Crossref
Qiang Wang, Hongtao Zhang, Shawn Guerrette, Jinqiu Chen, Anthony Mazurek, Teresa Wilson, Artur Slupianek, Tomasz Skorski, Richard Fishel & Mark I Greene. (2001) Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene 20:34, pages 4640-4649.
Crossref
Brian J Orelli, John M Logsdon Jr & Douglas K Bishop. (2001) Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20:32, pages 4433-4438.
Crossref
Christopher S Gilbert, Catherine M Green & Noel F Lowndes. (2001) Budding Yeast Rad9 Is an ATP-Dependent Rad53 Activating Machine. Molecular Cell 8:1, pages 129-136.
Crossref
Heinz Ruffner, Claudio A. P. Joazeiro, Dan Hemmati, Tony Hunter & Inder M. Verma. (2001) Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proceedings of the National Academy of Sciences 98:9, pages 5134-5139.
Crossref
Irene Garcia-Higuera, Toshiyasu Taniguchi, Shridar Ganesan, M.Stephen Meyn, Cynthia Timmers, James Hejna, Markus Grompe & Alan D D'Andrea. (2001) Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway. Molecular Cell 7:2, pages 249-262.
Crossref
Tamas I. Orban & Edith Olah. (2001) Expression Profiles of BRCA1 Splice Variants in Asynchronous and in G1/S Synchronized Tumor Cell Lines. Biochemical and Biophysical Research Communications 280:1, pages 32-38.
Crossref
Qiang Wang, Hongtao Zhang, Richard Fishel & Mark I Greene. (2000) BRCA1 and cell signaling. Oncogene 19:53, pages 6152-6158.
Crossref
Randal S. Tibbetts, David Cortez, Kathryn M. Brumbaugh, Ralph Scully, David Livingston, Stephen J. Elledge & Robert T. Abraham. (2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes & Development 14:23, pages 2989-3002.
Crossref
K. Sankaranarayanan & R. Chakraborty. (2000) Ionizing radiation and genetic risks. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 453:2, pages 129-181.
Crossref
Jiyong Zhao, Brian K. Kennedy, Brandon D. Lawrence, David A. Barbie, A. Gregory Matera, Jonathan A. Fletcher & Ed Harlow. (2000) NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription. Genes & Development 14:18, pages 2283-2297.
Crossref
Chu-Xia Deng & Steven G. Brodie. (2000) Roles of BRCA1 and its interacting proteins. BioEssays 22:8, pages 728-737.
Crossref
J. LiuM.D. HebertY. YeD.J. TempletonH. KungA.G. Matera. (2000) Cell cycle-dependent localization of the CDK2-cyclin E complex in Cajal (coiled) bodies. Journal of Cell Science 113:9, pages 1543-1552.
Crossref
Jong-Soo Lee, Kimberly M. Collins, Alexandra L. Brown, Chang-Hun Lee & Jay H. Chung. (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404:6774, pages 201-204.
Crossref
Piri L Welcsh, Kelly N Owens & Mary-Claire King. (2000) Insights into the functions of BRCA1 and BRCA2. Trends in Genetics 16:2, pages 69-74.
Crossref
T. CASPARI, C. DAVIES & A.M. CARR. (2000) Analysis of the Fission Yeast Checkpoint Rad Proteins. Cold Spring Harbor Symposia on Quantitative Biology 65:0, pages 451-456.
Crossref
David CortezYi WangJun QinStephen J. Elledge. (1999) Requirement of ATM-Dependent Phosphorylation of Brca1 in the DNA Damage Response to Double-Strand Breaks. Science 286:5442, pages 1162-1166.
Crossref
Ashok R. Venkitaraman. (1999) Breast Cancer Genes and DNA Repair. Science 286:5442, pages 1100-1102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.